Literature DB >> 22813880

An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis.

Piia-Riitta Karhemo1, Suvi Ravela, Marko Laakso, Ilja Ritamo, Olga Tatti, Selina Mäkinen, Steve Goodison, Ulf-Håkan Stenman, Erkki Hölttä, Sampsa Hautaniemi, Leena Valmu, Kaisa Lehti, Pirjo Laakkonen.   

Abstract

Details of metastasis, the deadliest aspect of cancer, are unclear. Cell surface proteins play central roles in adhesive contacts between the tumor cell and the stroma during metastasis. We optimized a fast, small-scale isolation of biotinylated cell surface proteins to reveal novel metastasis-associated players from an isogenic pair of human MDA-MB-435 cancer cells with opposite metastatic phenotypes. Isolated proteins were trypsin digested and analyzed using LC-MS/MS followed by quantitation with the Progenesis LC-MS software. Sixteen proteins displayed over twofold expression differences between the metastatic and non-metastatic cells. Interestingly, overexpression of most of them (14/16) in the metastatic cells indicates a gain of novel surface protein profile as compared to the non-metastatic ones. All five validated, differentially expressed proteins showed higher expression in the metastatic cells in culture, and four of these were further validated in vivo. Moreover, we analyzed expression of two of the identified proteins, CD109 and ITGA6 in 3-dimensional cultures of six melanoma cell lines. Both proteins marked the surface of cells derived from melanoma metastasis over cells derived from primary melanoma. The unbiased identification and validation of both known and novel metastasis-associated proteins indicate a reliable approach for the identification of differentially expressed surface proteins.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22813880      PMCID: PMC3508169          DOI: 10.1016/j.jprot.2012.07.009

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  66 in total

1.  Mitochondrial aspartate aminotransferase: direction of a single protein with two distinct functions to two subcellular sites does not require alternative splicing of the mRNA.

Authors:  M W Bradbury; P D Berk
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  Systematic variation in gene expression patterns in human cancer cell lines.

Authors:  D T Ross; U Scherf; M B Eisen; C M Perou; C Rees; P Spellman; V Iyer; S S Jeffrey; M Van de Rijn; M Waltham; A Pergamenschikov; J C Lee; D Lashkari; D Shalon; T G Myers; J N Weinstein; D Botstein; P O Brown
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

3.  Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro.

Authors:  Nikolaus Wick; Pipsa Saharinen; Juha Saharinen; Elisabeth Gurnhofer; Carl W Steiner; Ingrid Raab; Dejan Stokic; Pietro Giovanoli; Sabine Buchsbaum; Aurea Burchard; Stefan Thurner; Kari Alitalo; Dontscho Kerjaschki
Journal:  Physiol Genomics       Date:  2007-01-17       Impact factor: 3.107

4.  Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model.

Authors:  Paweena Kreunin; Chul Yoo; Virginia Urquidi; David M Lubman; Steve Goodison
Journal:  Proteomics       Date:  2007-01       Impact factor: 3.984

5.  Heat shock protein 70 and glycoprotein 96 are differentially expressed on the surface of malignant and nonmalignant breast cells.

Authors:  Karla Melendez; Erik S Wallen; Bruce S Edwards; Charlotte D Mobarak; David G Bear; Pope L Moseley
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

6.  CD109 expression levels in malignant melanoma.

Authors:  Yuichiro Ohshima; Ichiro Yajima; Mayuko Y Kumasaka; Takeshi Yanagishita; Daisuke Watanabe; Masahide Takahashi; Yuji Inoue; Hironobu Ihn; Yoshinari Matsumoto; Masashi Kato
Journal:  J Dermatol Sci       Date:  2010-01-07       Impact factor: 4.563

7.  Quantitative analysis of surface plasma membrane proteins of primary and metastatic melanoma cells.

Authors:  Haibo Qiu; Yinsheng Wang
Journal:  J Proteome Res       Date:  2008-04-15       Impact factor: 4.466

8.  Identification of metastasis-associated genes by transcriptional profiling of a pair of metastatic versus non-metastatic human mammary carcinoma cell lines.

Authors:  M Schwirzke; V Evtimova; H Burtscher; M Jarsch; D Tarin; U H Weidle
Journal:  Anticancer Res       Date:  2001 May-Jun       Impact factor: 2.480

9.  MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research.

Authors:  James M Rae; Chad J Creighton; Jeanne M Meck; Bassem R Haddad; Michael D Johnson
Journal:  Breast Cancer Res Treat       Date:  2006-09-27       Impact factor: 4.872

10.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

Authors:  Richard M Neve; Koei Chin; Jane Fridlyand; Jennifer Yeh; Frederick L Baehner; Tea Fevr; Laura Clark; Nora Bayani; Jean-Philippe Coppe; Frances Tong; Terry Speed; Paul T Spellman; Sandy DeVries; Anna Lapuk; Nick J Wang; Wen-Lin Kuo; Jackie L Stilwell; Daniel Pinkel; Donna G Albertson; Frederic M Waldman; Frank McCormick; Robert B Dickson; Michael D Johnson; Marc Lippman; Stephen Ethier; Adi Gazdar; Joe W Gray
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

View more
  12 in total

Review 1.  Stable isotope dilution mass spectrometry for membrane transporter quantitation.

Authors:  Vahid Farrokhi; Adam J McShane; Reza Nemati; Xudong Yao
Journal:  AAPS J       Date:  2013-10       Impact factor: 4.009

2.  Purification of Biotinylated Cell Surface Proteins from Rhipicephalus microplus Epithelial Gut Cells.

Authors:  Thomas P Karbanowicz; Ala Lew-Tabor; Manuel Rodriguez Valle
Journal:  J Vis Exp       Date:  2017-07-23       Impact factor: 1.355

3.  NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.

Authors:  Rikke R Lund; Rikke Leth-Larsen; Tina Di Caterino; Mikkel G Terp; Jeanette Nissen; Anne-Vibeke Lænkholm; Ole N Jensen; Henrik J Ditzel
Journal:  Mol Cell Proteomics       Date:  2015-09-08       Impact factor: 5.911

4.  TMED2 binding restricts SMO to the ER and Golgi compartments.

Authors:  Giulio Di Minin; Markus Holzner; Alice Grison; Charles E Dumeau; Wesley Chan; Asun Monfort; Loydie A Jerome-Majewska; Henk Roelink; Anton Wutz
Journal:  PLoS Biol       Date:  2022-03-30       Impact factor: 8.029

5.  A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.

Authors:  Michael J Schell; Mingli Yang; Edoardo Missiaglia; Mauro Delorenzi; Charlotte Soneson; Binglin Yue; Michael V Nebozhyn; Andrey Loboda; Gregory Bloom; Timothy J Yeatman
Journal:  Clin Cancer Res       Date:  2015-10-07       Impact factor: 12.531

6.  CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity.

Authors:  Pauliina Filppu; Jayendrakishore Tanjore Ramanathan; Kirsi J Granberg; Erika Gucciardo; Hannu Haapasalo; Kaisa Lehti; Matti Nykter; Vadim Le Joncour; Pirjo Laakkonen
Journal:  JCI Insight       Date:  2021-05-10

7.  Metastasis-associated cell surface oncoproteomics.

Authors:  Piia-Riitta Karhemo; Maija Hyvönen; Pirjo Laakkonen
Journal:  Front Pharmacol       Date:  2012-11-07       Impact factor: 5.810

8.  Identification of Extracellular Segments by Mass Spectrometry Improves Topology Prediction of Transmembrane Proteins.

Authors:  Tamás Langó; Gergely Róna; Éva Hunyadi-Gulyás; Lilla Turiák; Julia Varga; László Dobson; György Várady; László Drahos; Beáta G Vértessy; Katalin F Medzihradszky; Gergely Szakács; Gábor E Tusnády
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

9.  Coupling of Cell Surface Biotinylation and SILAC-Based Quantitative Proteomics Identified Myoferlin as a Potential Therapeutic Target for Nasopharyngeal Carcinoma Metastasis.

Authors:  Maoyu Li; Fang Peng; Guoqiang Wang; Xujun Liang; Meiying Shao; Zhuchu Chen; Yongheng Chen
Journal:  Front Cell Dev Biol       Date:  2021-06-09

10.  Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma.

Authors:  Bo-Gen Ye; Hui-Chuan Sun; Xiao-Dong Zhu; Zong-Tao Chai; Yuan-Yuan Zhang; Jian-Yang Ao; Hao Cai; De-Ning Ma; Cheng-Hao Wang; Cheng-Dong Qin; Dong-Mei Gao; Zhao-You Tang
Journal:  Oncotarget       Date:  2016-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.